Risk-Based Therapeutic Strategies for HER2-Positive Early Breast Cancer: A Consensus Paper. Garutti M, Cucciniello L, Arpino G, Fabi A, et al. Clin Breast Cancer 2023 Jul 26:S1526-8209(23)00202.

Read + Share

Amedeo Smart

Independent Medical Education

Garutti M, Cucciniello L, Arpino G, Fabi A, et al. Risk-Based Therapeutic Strategies for HER2-Positive Early Breast Cancer: A Consensus Paper. Clin Breast Cancer 2023 Jul 26:S1526-8209(23)00202.
PMID: 37543499